GENFIT

GENFIT Overview

Company Headquarters: Loos, France

Founded: 1999

Workforce: ~170

Company Working: GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases. The company is currently developing a non-invasive and easy-to-access blood-based IVD test to identify patients with NASH. Also, the company’s pipeline drug, Elafibranor is assessed under phase III clinical trial as a potential treatment for NASH. The company operates in only one segment, the research & development of innovative medicines. The company has its operational facilities in Lille and Paris, France, and Cambridge, Massachusetts, US.

Strategy

GENFIT aims to develop innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases. The company also focuses on value-based healthcare principles to drive global growth. GENFIT focuses on becoming a leading company in the field of liver disease diagnosis by entering into various strategic mergers and ventures.

Company Snapshot

$0.3M

Revenue

170

Employees

1999

Founded

Loos, France

Headquarters

SWOT Analysis

Strengths

Skilled workforce
Increasing globally presence

Weaknesses

Limited product portfolio comparted to well-established players

Opportunities

Mergers and acquisitions
New product developments

Threats

Changing competitive landscape

Key Developments

Date	Approach	Development
January 2019	Agreement	GENFIT and LabCorp signed a licensing agreement to expand access to NIS4, an innovative diagnostic assay for NASH. With this, the company aims to strengthen its position in the NASH biomarkers market.

Product Offering

GENFIT
- Blood-Based Biomarker Test

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.